The imaging of sentinel lymph nodes (SLNs), the first defense against primary tumor metastasis, has been considered as an important strategy for noninvasive tracking tumor metastasis in clinics. In this study, we report the development and application of mesoporous silica-based triple-modal nanoprobes that integrate multiple functional moieties to facilitate near-infrared optical, magnetic resonance (MR) and positron emission tomography (PET) imaging. After embedding near-infrared dye ZW800, the nanoprobe was labeled with T 1 contrast agent Gd 3þ and radionuclide
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Cu through chelating reactions. High stability and long intracellular retention time of the nanoprobes was confirmed by in vitro characterization, which facilitate long-term in vivo imaging. Longitudinal multimodal imaging was subsequently achieved to visualize tumor draining SLNs up to 3 weeks in a 4T1 tumor metastatic model. Obvious differences in uptake rate, amount of particles, and contrast between metastatic and contralateral sentinel lymph nodes were observed. These findings provide very helpful guidance for the design of robust multifunctional nanomaterials in SLNs' mapping and tumor metastasis diagnosis.
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Introduction
Sentinel lymph node (SLN) is the hypothetical first lymph node or group of nodes reached by metastasizing cancer cells from a primary tumor [1e3], and continues to be used as an important parameter in tumor staging and therapeutic decision-making. Thus, lymph node imaging can be applied to evaluate the metastatic status of a tumor. SLN imaging is based on an injected contrast agent near the primary tumor that is taken up by the adjacent lymphatic system and then transported to the SLN. Currently, vital dyes and radionuclide-labeled sulfur colloids are the most common imaging agents for SLN imaging [4] . However, these methods have a number of drawbacks. For instance, SLNs need to be dissected to observe the blue dye staining and lymphoscintigraphy requires radiation exposure with relatively low resolution. Therefore, various groups have performed studies to develop lymphatic imaging probes and imaging methods that would exceed the capabilities of the established "blue dye" procedure, and to improve identification and mapping of lymph nodes, especially sentinel lymph nodes during surgery [5e7] .
With the emergence of nanotechnology, several categories of nanoprobes have been developed to locate SLNs in living organisms, including quantum dots (QDs) [5,8e11] [16] . Based on their inherent properties, QDs and iron oxide can be detected and visualized by optical imaging or magnetic resonance imaging (MRI), respectively. When labeled with positron emitting radioisotopes, nanoprobes can be imaged with positron emission tomography (PET). However, each imaging modality has its own strengths and limitations. For example, MRI can provide three-dimensional tomography but is limited by low target sensitivity, whereas PET and optical imaging have good sensitivity but suffer from low spatial resolution or tissue penetration. To harness the strengths of
